Pharma Journalist -

Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved ICOTYDE™ (icotrokinra), a novel oral therapy for the treatment of moderate-to-severe…
Read More...

Voro Therapeutics has entered into a research collaboration with Daiichi Sankyo to develop next-generation antibody-drug conjugates (ADCs) using its proprietary PrimeBody platform. The…
Read More...

Terumo Blood and Cell Technologies (Terumo BCT) has entered into a strategic collaboration with Taiwan Bio Therapeutics Inc. to advance the manufacturing of regulatory T-cell (Treg)…
Read More...

R1 Therapeutics has officially launched as a new clinical-stage biopharmaceutical company, backed by an oversubscribed $77.5 million Series A financing and a strategic licensing…
Read More...

Sun Pharmaceutical Industries Limited has announced that the U.S. Food and Drug Administration (FDA) has accepted for review its supplemental Biologics License Application (sBLA) for…
Read More...

Aldeyra Therapeutics has received a setback in its efforts to bring a new treatment for dry eye disease to market, following a Complete Response Letter (CRL) issued by the U.S. Food and…
Read More...

For fast‑growing digitalization leaders like Uncountable, accessing the right scientific and R&D decision makers is essential. Before joining the SmartLab Exchange USA, the company…
Read More...

Across materials science, chemistry, and pharmaceutical R&D, laboratories are moving beyond slow, sequential experimentation toward AI‑integrated discovery. One of the most…
Read More...

Roche has announced a major expansion of its global artificial intelligence (AI) infrastructure, unveiling a large-scale “AI factory” powered by next-generation accelerated computing…
Read More...

Sentynl Therapeutics, a U.S.-based biopharmaceutical company and a wholly owned subsidiary of Zydus Lifesciences, has entered into a licensing agreement with South Korea-based PRG…
Read More...